FDA Inspection 1035038 — Apotex Research Private Limited
The FDA completed an inspection of Apotex Research Private Limited on Nov 17, 2017 in Bengaluru. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 17, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)